Oura Ring Maker Eyes IPO with $11B Valuation

The smart ring pioneer, Oura, has taken a significant step towards public trading by confidentially submitting a registration statement to the U.S. Securities and Exchange Commission. This move signals the company's readiness to transition from a privately held entity to a publicly traded one, pending regulatory review and favorable market conditions.

This strategic maneuver follows a substantial funding round in October 2025, which saw Oura secure $900 million. The investment was spearheaded by Fidelity Management and Research Company, with significant participation from ICONIQ, alongside existing investors Whale Rock and Atreides. This infusion of capital underscores the strong investor confidence in Oura's growth trajectory and its position within the rapidly expanding wearable technology and digital health sectors.

The recent financing round cemented Oura's status as the world's most valuable independent wearable company, achieving an impressive valuation of approximately $11 billion. This valuation is supported by robust commercial performance. Since its inception in 2015, the company has sold over 5.5 million Oura Rings, with a remarkable acceleration in sales, as more than half of these units were purchased in the past year alone. Financial figures further bolster this valuation, with 2024 revenues surpassing $500 million, effectively doubling from the previous year. Projections for 2025 indicate another year of doubling revenue, aiming for over $1 billion, coupled with enhanced profitability, according to CEO Tom Hale.

Beyond its hardware success, Oura is strategically positioning itself as a comprehensive preventive health platform. The company's flagship product, the Oura Ring, meticulously monitors over 50 health indicators, encompassing sleep patterns, physical activity, stress levels, cardiovascular health, and women's health metrics. This data-driven approach has fostered a broad ecosystem, connecting with over 1,200 wellness and medical partners, as well as numerous research institutions and healthcare providers. Notably, the fastest-growing demographic for Oura's services is women in their early twenties, highlighting a key market segment.

In a significant technological advancement, Oura unveiled its proprietary Large Language Model in February 2026. Developed in collaboration with webAI, a specialist in privacy-centric AI architectures, this model is integrated into the Oura Advisor chatbot. It is specifically engineered to address the complexities of women's health, from menstrual cycle tracking to menopausal support. This development aligns with a broader industry trend where tech companies are building their own AI infrastructure, rather than solely relying on third-party models. The company emphasizes that its AI is hosted entirely on its own servers, ensuring user conversations are neither shared nor sold, reinforcing its commitment to data privacy and responsible AI development.

The introduction of this specialized AI, accessible through the opt-in Oura Labs experimental platform, analyzes biometric signals related to sleep, activity, cycle, pregnancy, and stress. It synthesizes this personal data with clinically vetted medical knowledge, offering users deeper insights. This strategic push into proprietary AI, combined with its strong market traction and impending IPO, signals Oura's ambition to evolve from a wearable device manufacturer into a leading force in personalized, preventive healthcare.